Return to school practices after hematopoietic cell transplantation: a survey of transplant centers in the United States

Neel S. Bhatt(The Ohio State University Wexner Medical Center), Rachel Phelan(Medical College of Wisconsin), Sung Won Choi(University of Michigan), Christa L. Meyer(National Marrow Donor Program), Christopher E. Dandoy(Cincinnati Children's Hospital Medical Center), Jeffery J. Auletta(Nationwide Children's Hospital), Larisa Broglie(Morgan Stanley Children's Hospital), K. Scott Baker(University of Washington), Steven M. Devine(National Marrow Donor Program), Lih-Wen Mau(Tamkang University), Paul A. Carpenter(Fred Hutch Cancer Center)
Bone Marrow Transplantation
February 20, 2024
10.1038/s41409-024-02239-w
Cited by 6

Related Papers

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study
|Blood|2007|536